NDC 83513-009 – Beizray

Docetaxel Anhydrous 20 mg/mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC83513-009

Product details

Brand name
Beizray
Generic name
Docetaxel
Labeler
Zhuhai Beihai Biotech Co., Ltd.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
NDA · NDA218711
Marketed since
October 23, 2024
Listing expires
December 31, 2026
Pharmacologic class
Microtubule Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Beizray →

Package NDC codes (1)

Package NDCDescriptionSince
83513-009-014 mL in 1 VIAL, GLASS (83513-009-01)Oct 23, 2024

Other Beizray products